Abstract
BACKGROUND: Pretomanid (Pa) is a nitroimidazoleclass drug recently approved by the US Food and Drug Administration and other regulatory authorities as......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
